Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- The Pfizer-Shire Deal Worst-Case Scenario
- Earlier this week shares of Shire rose on rumors that Pfizer may be interested in acquiring the company, which is best-known for its ADHD drug Adderall XR. The notion that Pfizer is in acquisition mode has been driving people crazy for days. (See BNET's coverage of Pfizer Pfever here.) ...
- Blog posts 2009-01-07
Additional Resources
- Michael Phelps' Mom Exits McNeil's ADHD Facebook Page
- Debbie Phelps, mother of Olympic swimmer Michael Phelps, has gone from McNeil's Facebook page, ADHD Moms, according to blogger John Mack. The move follows Michael Phelps' loss of many of his endorsement contracts because he was photographed sucking on a marijuana bong. UPDATE: A...
- Blog posts 2009-03-12
- Shire's Big Gamble on ADHD Drug Vyvanse
- One of the recent unheralded successes of the drug world was Shire Pharmaceuticals' launch of Vyvanse, a new, long-acting treatment for attention deficit and hyperactivity disorder. The fact that so little attention has been paid to Vyvanse is a shame because the take-up of this drug has been impressive --...
- Blog posts 2008-09-04
- The ADHD Conundrum.
- 00-00-0000 Introduction to the special series on attention- deficit/hyperactivity disorder Professionals working within special and remedial education are often concerned about the specific nature of attention-deficit/hyperactivity disorders ADHD and how to both manage ADHD students in the classroom and provide appropriate and successful...
- Research articles 1995-03-01
- ADHD and dyscalculia: evidence for independent familial transmission.(attention-deficit/hyperactivity disorder)
- Several studies have documented the co-occurrence of attention-deficit/hyperactivity disorder ADHD and learning disabilities LD in youth. For example, our group reported a significant association between ADHD and LD in a clinical sample of children with ADHD (Semrud-Clikeman et al., 1992). Others have also found associations...
- Research articles 2005-01-01
- Doubts cast on safety of ADHD medications.
- Byline: Clara Pirani Sep 18, 2005 (The Australian - ABIX via COMTEX) -- A US study of drugs used to treat attention deficit hyperactivity disorder ADHD in children has drawn...
- Research articles 2005-09-18
- Australia a leader in ADHD drug use.
- Byline: Cathy O'Leary Mar 07, 2007 (The West Australian - ABIX via COMTEX) -- New research confirms Australia is a major prescriber of psychostimulant drugs to treat attention deficit and hyperactivity disorder ADHD. Research at the University of California, Berkeley found a 300 increase...
- Research articles 2007-03-07
- Neuropsychological and Behavioral Assessment of ADHD in Seven- to Twelve-Year-Old Children: A Discriminant Analysis.
- The results of a study on Attention Deficit/Hyperactivity Disorder ADHD suggest it is not practical to administer a wide range of neuropsychological tests in order to evaluate ADHD. Tests assessing attention, memory, visuoconstructional abilities and executive function may be included. It is also suggested that tests assessing primary cognitive functions...
- Research articles 1999-03-01
- Treatment of ADHD with stimulant medications: response to Nissen perspective in The New England Journal of Medicine.(attention-deficit/hyperactivity disorder)(Steven E. Nissen)(Viewpoint essay)
- This article is a response to Dr. Steven E. Nissen's comments (Nissen, 2006) about attention-deficit/hyperactivity disorder ADHD and its treatment with stimulant medications. For many years we have worked as clinicians caring for children, adolescents, and adults with ADHD and their families and as researchers characterizing...
- Research articles 2006-10-01
- Net addiction linked to ADHD in teens
- Children and teens with ADHD, or who are depressed or hostile, may be prone to becoming addicted to using the internet, a new study suggests. Internet addiction is not an official diagnosis by the American Psychiatric Association, but some experts consider it a potential problem if it interferes with everyday...
- News items 2009-10-05
- Seeing Time: 6 Practical Steps To Manage Time Successfully With ADHD
- For many people time advances in front of them and falls away behind in an orderly fashion like the crossties on the railroad tracks. They are able to estimate how much time has elapsed or organize future tasks neatly to fit the time available. Others, especially people with Attention Deficit...
- White papers 2007-12-01
- NMHA Applauds FDA Review of ADHD Medications for Youth; Calls for Attention to Untreated Mental Disorders in Children
- ALEXANDRIA, Va., March 22 /U.S. Newswire/ -- Following is a statement by Cynthia Wainscott, acting president and CEO of NMHA, on the FDA review of ADHD medications for youth: ALEXANDRIA, Va., March 22 /U.S. Newswire/ -- Following is a statement by Cynthia Wainscott, acting president and CEO of NMHA, on...
- Research articles 2006-03-22
- APA Urges FDA to Rely on Science, Not Anecdote Alone, for Regulating ADHD Drugs
- ARLINGTON, Va. March 22 /U.S. Newswire/ -- In testimony today, the American Psychiatric Association APA told the Food and Drug Administration FDA that more research is needed in the area of attention-deficit/hyperactivity disorder ADHD and rare adveARLINGTON, Va. March 22 /U.S. Newswire/ -- In testimony today, the American Psychiatric Association...
- Research articles 2006-03-22
- Eli Lilly's Strattera approved for treating symptoms of ADHD
- The FDA has approved the first new drug in three decades for treating symptoms of attention deficit/hyperactivity disorder ADHD including inattention, hyperactivity and impulsiveness - Eli Lilly and Co.'s Strattera atomoxetine. Strattera, the agency said, has a different mechanism of action from stimulant-like drugs traditionally used in treating ADHD (it...
- Research articles 2003-01-01
- Shire Pharmaceuticals Group PLC - Positive clinical data for transdermal ADHD treatment.
- Shire and Noven announce positive clinical data for transdermal ADHD treatment Embargoed until 08:00 ET / 13:00 BST Basingstoke UK and Philadelphia, US - April 6, 2005 - Shire Pharmaceuticals Group plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) today aShire...
- Research articles 2005-04-06
- FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
- Eli Lilly and Company (NYSE: LLY) announced today that the United States Food and Drug Administration FDA has approved Strattera® atomoxetine HCI for maintenance treatment of Attention-Deficit/Hyperactivity Disorder ADHD in children and adolescents. Strattera, a selective norepinephrine reuptake inhibitor, is the first FDA-approved non-stimulant to treat ADHD in children,...
- Research articles 2008-05-08
- Sciele Pharma Announces That Addrenex Has Completed Enrollment of Pivotal Phase III Trial for Clonicel for ADHD
- ATLANTA -- Sciele Pharma, Inc. (NASDAQ: SCRX), a specialty pharmaceutical company, today announced that Addrenex Pharmaceuticals has completed patient enrollment of its first Phase III clinical trial in the U.S. for Clonicel to treat attention deficit and hyperactivity disorder ADHD in children. Addrenex is also continuing to enroll patients in...
- Research articles 2008-06-03
- Sciele Pharma and Addrenex Announce Initiation of Pivotal Phase III Trials for Clonicel for ADHD
- ATLANTA -- Sciele Pharma, Inc. (NASDAQ:SCRX), a specialty pharmaceutical company, and Addrenex Pharmaceuticals, today announced the initiation of patient enrollment for Phase III clinical trials in the U.S. for Clonicel to treat attention deficit and hyperactivity disorder ADHD in children. In July 2007, Sciele signed an exclusive licensing agreement with...
- Research articles 2007-10-30
- The quest to unlock the mysteries of ADHD.
- Byline: Julie Robotham Sep 13, 2006 (The Sydney Morning Herald - ABIX via COMTEX) -- Alasdair Vance, of the University of Melbourne, addressed the International Congress of Neuropsychiatry in September 2006. Vance outlined how brain scanning and genetic research are advancing our ...
- Research articles 2006-09-13
- ADHD and achievement: meta-analysis of the child, adolescent, and adult literatures and a concomitant study with college students.(attention deficit hyperactivity disorder )
- Poor academic performance is among the most prominent features associated with attention-deficit/hyperactivity disorder ADHD. Findings reported in a substantial literature have indicated that individuals with ADHD are at risk for a range of academic complications, including a higher incidence of failing grades, elevated rates of grade...
- Research articles 2007-01-01
- << Previous
- page 1 of 1
- Next >>
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
